miR-182 by direct targeting 3’-UTR of ST6GALNAC2 and consequent activation of PI3K/Akt pathway increases 5-FU resistance in CRC cells and causes CRC progression [83]. The gene discussed is AKT1; the disease is colorectal carcinoma.